A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma
Open Access
- 1 September 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (17), 5565-5570
- https://doi.org/10.1158/1078-0432.ccr-08-0544
Abstract
Purpose: Clinical staging does not adequately risk stratify patients with early stage non–small cell lung cancer. We sought to generate a real-time PCR (RT-PCR)–based prognostic model in patients with early stage lung adenocarcinoma, the dominant histology of lung cancer in the United States. Experimental Design: We studied gene expression of 61 candidate genes in 107 patients with completely surgically resected lung adenocarcinoma using RT-PCR. We used crossvalidation methods to select and validate a prognostic model based on the expression of a limited number of genes. A risk score was generated based on model coefficients, and survival of patients with high- and low-risk scores were analyzed. Results: We generated a four-gene model based on expression of WNT3a, ERBB3, LCK, and RND3. Risk score predicted mortality better than clinical stage or tumor size (adjusted hazard ratio, 6.7; 95% confidence interval, 1.6-28.9; P = 0.001). Among 70 patients with stage I disease, 5-year overall survival was 87% among patients with low-risk scores, and 38% among patients with high-risk scores (P = 0.0002). Among all patients, 5-year overall survival was 62% and 41%, respectively (P = 0.0054). Disease-free survival was also significantly different among low- and high-risk score patients. Conclusions: This multigene assay predicts overall and disease-free survival significantly better than clinical stage and tumor size in patients with early stage lung adenocarcinoma and performs especially well in patients with stage I disease. Prospective clinical trials are needed to determine whether high-risk patients with stage I disease benefit from adjuvant chemotherapy.Keywords
Other Versions
This publication has 30 references indexed in Scilit:
- L1-Regularization Path Algorithm for Generalized Linear ModelsJournal of the Royal Statistical Society Series B: Statistical Methodology, 2007
- Adjuvant Chemotherapy of Stage I Non-small Cell Lung Cancer in North AmericaJournal of Thoracic Oncology, 2007
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisitedBiostatistics, 2005
- Wnt signaling in lung cancerCancer Letters, 2005
- Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression dataBioinformatics, 2005
- Small G‐protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosisThe Prostate, 2005
- Identification of Metastasis-Associated Receptor Tyrosine Kinases in Non–Small Cell Lung CancerCancer Research, 2005
- Least angle regressionThe Annals of Statistics, 2004
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002